BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17519277)

  • 21. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    Ann Rheum Dis; 1996 Oct; 55(10):756-60. PubMed ID: 8984942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.
    Thanou A; James JA; Arriens C; Aberle T; Chakravarty E; Rawdon J; Stavrakis S; Merrill JT; Askanase A
    Lupus Sci Med; 2019; 6(1):e000365. PubMed ID: 31921432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.
    Devilliers H; Bonithon-Kopp C; Jolly M
    Lupus; 2017 Apr; 26(4):396-402. PubMed ID: 27587460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.
    Gordon C; Wallace DJ; Shinada S; Kalunian KC; Forbess L; Braunstein GD; Weisman MH
    Rheumatology (Oxford); 2008 Mar; 47(3):334-8. PubMed ID: 18238794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
    Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition and treatment of lupus flares measured by the BILAG index.
    Gordon C; Sutcliffe N; Skan J; Stoll T; Isenberg DA
    Rheumatology (Oxford); 2003 Nov; 42(11):1372-9. PubMed ID: 12810926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus.
    Mina R; Abulaban K; Klein-Gitelman MS; Eberhard BA; Ardoin SP; Singer N; Onel K; Tucker L; O'neil K; Wright T; Brooks E; Rouster-Stevens K; Jung L; Imundo L; Rovin B; Witte D; Ying J; Brunner HI
    Arthritis Care Res (Hoboken); 2016 Feb; 68(2):195-202. PubMed ID: 26213987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.
    Yee CS; Farewell VT; Isenberg DA; Griffiths B; Teh LS; Bruce IN; Ahmad Y; Rahman A; Prabu A; Akil M; McHugh N; Edwards C; D'Cruz D; Khamashta MA; Gordon C
    Rheumatology (Oxford); 2011 May; 50(5):982-8. PubMed ID: 21245073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows.
    Ceccarelli F; Perricone C; Massaro L; Cipriano E; Alessandri C; Spinelli FR; Valesini G; Conti F
    Autoimmun Rev; 2015 Jul; 14(7):601-8. PubMed ID: 25742757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort.
    David T; Su L; Cheng Y; Gordon C; Parker B; Isenberg D; Reynolds JA; Bruce IN; ;
    Lupus; 2023 Aug; 32(9):1043-1055. PubMed ID: 37463793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index with measures of disease activity and health status in patients with systemic lupus erythematosus.
    Stoll T; Stucki G; Malik J; Pyke S; Isenberg DA
    J Rheumatol; 1997 Feb; 24(2):309-13. PubMed ID: 9034988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
    J Rheumatol; 1992 Apr; 19(4):608-11. PubMed ID: 1593583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the clinical activity of systemic lupus erythematosus].
    Le Loët X
    Ann Med Interne (Paris); 1990; 141(3):261-4. PubMed ID: 2195948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematosus disease activity index 2000 responder index-50: a reliable index for measuring improvement in disease activity.
    Touma Z; Urowitz MB; Fortin PR; Landolt C; Toloza SM; Riddell C; Chandran V; Eder L; Ghanem A; Ziouzina O; Taghavi-Zadeh S; Ibañez D; Gladman DD
    J Rheumatol; 2011 May; 38(5):868-73. PubMed ID: 21324961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preliminary test of the LFA rapid evaluation of activity in lupus (LFA-REAL): an efficient outcome measure correlates with validated instruments.
    Askanase A; Li X; Pong A; Shum K; Kamp S; Carthen F; Aberle T; Hanrahan L; Daly P; Giles J; Merrill JT
    Lupus Sci Med; 2015; 2(1):e000075. PubMed ID: 25861457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How should lupus flares be measured? Deconstruction of the safety of estrogen in lupus erythematosus national assessment-systemic lupus erythematosus disease activity index flare index.
    Thanou A; Chakravarty E; James JA; Merrill JT
    Rheumatology (Oxford); 2014 Dec; 53(12):2175-81. PubMed ID: 24729400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.